Skip to main content

Oliveda International, Inc. (OLVI) Achieves 56% Growth in 2019, Plans Over 100% in 2020

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

SANTA MONICA, CA, Jan. 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, today announced that the company achieved 56% growth in 2019 and is planning additional growth of over 100% in 2020.
After being upgraded to “Pink Current Information” on the OTC Markets Group website in March 2019, the company obtained FDA registration approval for all Oliveda products in April and had its U.S. launch on https://us.oliveda.com in May.  Oliveda also launched many new products in 2019, including our Beauty Molecule, which was met with immediate success, entering the company’s top ten bestselling products within just a few weeks.New companies and brands were developed in 2020, such as LA DOPE, Olive Tree People, and Oliveda America, as well as new technologies that are unique in the world and sales contracts for more than 20,000 of our own mountain olive trees.  Oliveda obtained retail approval for the China market and launched a globally unique CBD technology that can be used immediately worldwide without further approvals, and thus creates new sales channels.Oliveda founder and CEO Thomas Lommel commented, “In addition to these many developments in 2019, we ended the year with growth of 56%.  Based on all these preparations, we plan to achieve growth of over 100% in 2020 and target a listing on the Nasdaq in 2021.”Oliveda International Inc. Founded in 2003 by German real estate investor Thomas Lommel, Oliveda International, Inc. is a leading international natural cosmetic company in the premium segment.  The company has also developed a globally unique wearable beauty and health technology. In addition to online sales and a global branch network of 650 retail stores, the company’s wholly owned Oliveda Deutschland GmbH subsidiary operates flagship stores, Olive Tree Pharmacy, in Berlin and Dusseldorf with plans to open new locations in Los Angeles, Taipei and Seoul.  Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next five years. Through subsidiary operations, Oliveda International is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinos de Leó, Spain.  Further information on Oliveda International can be found at http://www.oliveda.com, us.oliveda.com and http://www.olivetreepeople.com.    Forward-Looking StatementsThis press release may contain statements, estimates or projections that constitute “forward-looking statements” pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties, which may be found in the Company’s filings with OTC Markets Group Inc., that could cause actual results to differ materially from the Company’s historical experience and present expectations or projections. Investors should not place undue reliance on forward-looking statements, which speak only as of the date they are made.  The Company expressly disclaims any obligation or intention to publicly update or revise any forward-looking statements unless otherwise required by law.Advance PR Group, LLC
619-202-7456
olvi@advanceprgroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.